ASCENT26 Applications Now Open

ASCENT is Capital BioVentures' six-month cohort program built for pre-seed and seed stage Canadian therapeutics companies to get investor-ready.

During the program, companies will work through corporate development, product development, and financing strategy, with expert-led seminars, open office hours, 1:1 coaching from experienced biotech executives, pitch practice sessions, investor introductions, and so much more. Companies will pitch to investors at the CBV Pitch Competition, with a cash prize available.

All companies will be presented with a final diligence report summarizing opportunities to accelerate growth. Based on final diligence assessments, select companies will be invited to the prestigious RIDGE and SUMMIT accelerator, becoming part of the CBV portfolio.

Application deadline: August 3, 2026

Program launch: September 15, 2026

For more info, write to the team.